These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. siRNA conjugates carrying sequentially assembled trivalent N-acetylgalactosamine linked through nucleosides elicit robust gene silencing in vivo in hepatocytes. Matsuda S; Keiser K; Nair JK; Charisse K; Manoharan RM; Kretschmer P; Peng CG; V Kel'in A; Kandasamy P; Willoughby JL; Liebow A; Querbes W; Yucius K; Nguyen T; Milstein S; Maier MA; Rajeev KG; Manoharan M ACS Chem Biol; 2015 May; 10(5):1181-7. PubMed ID: 25730476 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of Monovalent N-Acetylgalactosamine Phosphoramidite for Liver-Targeting Oligonucleotides. Yamamoto T; Terada C; Kashiwada K; Yamayoshi A; Harada-Shiba M; Obika S Curr Protoc Nucleic Acid Chem; 2019 Sep; 78(1):e99. PubMed ID: 31529782 [TBL] [Abstract][Full Text] [Related]
9. The Nonclinical Safety Profile of GalNAc-conjugated RNAi Therapeutics in Subacute Studies. Janas MM; Harbison CE; Perry VK; Carito B; Sutherland JE; Vaishnaw AK; Keirstead ND; Warner G Toxicol Pathol; 2018 Oct; 46(7):735-745. PubMed ID: 30139307 [TBL] [Abstract][Full Text] [Related]
10. Application of improved GalNAc conjugation in development of cost-effective siRNA therapies targeting cardiovascular diseases. Li Q; Yin K; Ma HP; Liu HH; Li S; Luo X; Hu R; Zhang WW; Lv ZS; Niu XL; Gu MH; Li CL; Liu YS; Liu YJ; Li HB; Li N; Li C; Gu WW; Li JJ Mol Ther; 2024 Mar; 32(3):637-645. PubMed ID: 38204163 [TBL] [Abstract][Full Text] [Related]
11. Plasma Pharmacokinetics of N-Acetylgalactosamine-Conjugated Small-Interfering Ribonucleic Acids (GalNAc-Conjugated siRNAs). Sten S; Cardilin T; Antonsson M; Gennemark P Clin Pharmacokinet; 2023 Dec; 62(12):1661-1672. PubMed ID: 37824025 [TBL] [Abstract][Full Text] [Related]
12. Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing. Nair JK; Willoughby JL; Chan A; Charisse K; Alam MR; Wang Q; Hoekstra M; Kandasamy P; Kel'in AV; Milstein S; Taneja N; O'Shea J; Shaikh S; Zhang L; van der Sluis RJ; Jung ME; Akinc A; Hutabarat R; Kuchimanchi S; Fitzgerald K; Zimmermann T; van Berkel TJ; Maier MA; Rajeev KG; Manoharan M J Am Chem Soc; 2014 Dec; 136(49):16958-61. PubMed ID: 25434769 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and Pharmacodynamics of GalNAc-Conjugated siRNAs. An G J Clin Pharmacol; 2024 Jan; 64(1):45-57. PubMed ID: 37589246 [TBL] [Abstract][Full Text] [Related]
14. Purification of N-acetylgalactosamine-modified-oligonucleotides using orthogonal anion-exchange and mixed-mode chromatography approaches. Kazarian AA; Barnhart W; Long J; Sham K; Wu B; Murray JK J Chromatogr A; 2022 Jan; 1661():462679. PubMed ID: 34871941 [TBL] [Abstract][Full Text] [Related]